Schedule 13D ownership disclosure
Stealth BioTherapeutics Corp
Security class unavailable · CUSIP: 85788D100
Event date: 2022-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 740,265,268
- Percent of class
- 66.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-074808
- Form type
- SC 13D
- Filer
- Morningside Venture (I) Investments Ltd
- CIK
- CIK 1770194
- Filed
- Jun 27, 2022
- Reporting period
- Jun 24, 2022
- Description
- Schedule 13D beneficial ownership